Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/19/2025
HighTide's HTD1801 Meets Goals in Two Phase 3 Diabetes Trials
4/19/2025
China Approves AstraZeneca's Truqap for Advanced HR+/HER2– Breast Can...
4/19/2025
Akeso's Ebdarokimab Approved in China as First Domestic IL-12/IL-23 An...
4/19/2025
Haleon Achieves Full Ownership of Tianjin SmithKline JV
4/19/2025
China Issues New Guidelines to Streamline Mainland Registration for Or...
4/18/2025
VelaVigo and Ollin Biosciences Ink ex-Greater China Licensing Deal for...
4/18/2025
WuXi Biologics Completes 15,000L PPQ at Hangzhou Site
4/18/2025
Chinese drugmakers weigh options as US mulls pharma tariffs (KrAsia)
4/17/2025
This Pharma Company Is Betting Big On A Chinese Ozempic Rival (Forbes)
4/17/2025
Interpretation of the Anti-Monopoly Guidelines for Pharmaceutical Sect...
4/17/2025
BMS Launches Head-to-Head Phase 1 Trial for SystImmune-Licensed EGFR/H...
4/17/2025
DualityBio Raises $211M in Hong Kong IPO
4/17/2025
InnoCare's Zurletrectinib NDA Accepted by China's NMPA for NTRK Fusion...
4/17/2025
Eli Lilly's Mirikizumab Advances in China with New Indication Filing
4/17/2025
Akeso Advances Second ADC into Clinical Trials with TROP2/Nectin-4 Bis...
4/17/2025
Sanofi Secures Global Rights to AI-Discovered BsAb in $1.8B+ Deal with...
4/17/2025
Hengrui Advances CD79b-Targeted ADC SHR-A1912 into Phase 3 Trial for R...
4/17/2025
Latticon Pioneers China's First Pipeline-Backed Financing Deal
4/17/2025
Eddingpharm to Take Over Genor in HKEX's First 18A Reverse Merger
4/17/2025
WuXi AppTec Cashes Out of WuXi XDC as U.S. Tariff Threats Mount
4/17/2025
Pharma Giants Already Moving to Cut Reliance on China Amid Tariff Unce...
4/15/2025
Gardasil9 Gains Expanded Approval in China
4/15/2025
China NMPA Approves Kowa's Parmodia (Pemafibrate) for Dyslipidemia Tre...
4/15/2025
Chinese Pharma Companies Rethink Global Strategies as US Considers Dru...
4/15/2025
U.S. Tariff Threat on Chinese Pharma Could Reshape Landscape for India...
4/15/2025
Akeso Initiates First Clinical Trial for AK139, Its First Non-Oncology...
4/15/2025
Off-Label Drug Use in China After the Physician Law (2021): Legal Chal...
4/14/2025
Trump vs China Biotech: Who Will Emerge Victorious in the Tariff Trade...
4/14/2025
China's Online Pharmacy Market Surpasses CNY 70B: WMs Gain Ground as D...
4/14/2025
Sirius Receives FDA IND Clearance for FIC siRNA Therapy SRSD216 Target...
Page:
1
/
761
Total number of articles:
22823
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit